Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles H McDonnell

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Familial Cancer|April 16, 2013
Self administered screening for hereditary cancers in conjunction with mammography and ultrasoundCharles H McDonnell, David J Seidenwurm, Diana E McDonnell, et al.
Lancet (London, England)|October 7, 2023
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort studyDeb Schrag, Tomasz M Beer, Charles H McDonnell, et al.
The Lancet. Oncology|January 16, 2025
Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort studyLincoln Nadauld, Charles H McDonnell, Christina A Dilaveri, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 23, 2025
Clinical Evaluation of Cancer Signal Origin Prediction and Diagnostic Resolution Following Multi-Cancer Early Detection Testing in the PATHFINDER StudyCatherine R Marinac, Charles H McDonnell, Lincoln D Nadauld, et al.
Cancers|July 24, 2021
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical PracticeLincoln D Nadauld, Charles H McDonnell, Tomasz M Beer, et al.
Cancer Discovery|June 28, 2017
Immune Escape in Breast Cancer During <i>In Situ</i> to Invasive Carcinoma TransitionCarlos R Gil Del Alcazar, Sung Jin Huh, Muhammad B Ekram, et al.
Cancer Cell|April 17, 2026
Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progressionTriet Minh Bui, Ernesto Rojas Jimenez, Zheqi Li, et al.
Nature Communications|September 15, 2019
Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situLina Ding, Ying Su, Anne Fassl, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Familial Cancer|April 16, 2013
Self administered screening for hereditary cancers in conjunction with mammography and ultrasoundCharles H McDonnell, David J Seidenwurm, Diana E McDonnell, et al.
Lancet (London, England)|October 7, 2023
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort studyDeb Schrag, Tomasz M Beer, Charles H McDonnell, et al.
The Lancet. Oncology|January 16, 2025
Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort studyLincoln Nadauld, Charles H McDonnell, Christina A Dilaveri, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 23, 2025
Clinical Evaluation of Cancer Signal Origin Prediction and Diagnostic Resolution Following Multi-Cancer Early Detection Testing in the PATHFINDER StudyCatherine R Marinac, Charles H McDonnell, Lincoln D Nadauld, et al.
Cancers|July 24, 2021
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical PracticeLincoln D Nadauld, Charles H McDonnell, Tomasz M Beer, et al.
Cancer Discovery|June 28, 2017
Immune Escape in Breast Cancer During <i>In Situ</i> to Invasive Carcinoma TransitionCarlos R Gil Del Alcazar, Sung Jin Huh, Muhammad B Ekram, et al.
Cancer Cell|April 17, 2026
Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progressionTriet Minh Bui, Ernesto Rojas Jimenez, Zheqi Li, et al.
Nature Communications|September 15, 2019
Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situLina Ding, Ying Su, Anne Fassl, et al.
Pageof 1